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Abstract
Background: The DAOA/G30 (D-amino acid oxidase activator) gene complex at chromosomal region 13q32-33 is
one of the most intriguing susceptibility loci for the major psychiatric disorders, although there is no consensus
about the specific risk alleles or haplotypes across studies.
Methods: In a case-control sample of German descent (affective psychosis: n = 248; controls: n = 188) we
examined seven single nucleotide polymorphisms (SNPs) around DAOA/G30 (rs3916966, rs1935058, rs2391191,
rs1935062, rs947267, rs3918342, and rs9558575) for genetic association in a polydiagnostic approach (ICD 10;
Leonhard’s classification).
Results: No single marker showed evidence of overall association with affective disorder neither in ICD10 nor
Leonhard’s classification. Haplotype analysis revealed no association with recurrent unipolar depression or bipolar
disorder according to ICD10, within Leonhard’s classification manic-depression was associated with a 3-locus
haplotype (rs2391191, rs1935062, and rs3916966; P = 0.022) and monopolar depression with a 5-locus combination
at the DAOA/G30 core region (P = 0.036).
Conclusion: Our data revealed potential evidence for partially overlapping risk haplotypes at the DAOA/G30 locus
in Leonhard’s affective psychoses, but do not support a common genetic contribution of the DAOA/G30 gene
complex to the pathogenesis of affective disorders.
Background
Based on whole-genome linkage data large proportions
of the distal chromosome 13q (spanning < 50 cM) have
been proposed as regions containing genes for schizo-
phrenia, bipolar disorder, autism, anorexia and panic
disorder [1,2]. In a systematic analysis targeting on a < 5
Mb segment at the distal region of chromosome 13q32-
33, Chumakov et al. described two candidate genes for
schizophrenia, DAOA and G30, overlapping on comple-
mentary chromosomal strands with opposite orienta-
tions (Figure 1) [3]. DAOA consists of five exons,
spanning a region of < 25 kb, encoding 742 bp of puta-
tive mRNA, whereas G30 spans < 47 kb and the longest
potential open reading frame encodes a 71-amino acid
protein (Figure 1), [3]. Along with the discovery of G72/
DAOA, a neurochemical cascade was launched that
introduced G72/DAOA as part of the central glutamate
system, which plays an essential role in the formation of
memory, synaptic plasticity and neuronal development.
G72 was renamed D-amino acid oxidase activator
(DAOA) since initial experiments proposed G72 as
potent interacting partner of D-amino acid oxidase
(DAO) increasing NMDA transmission via D-serine
oxidation [3].
Subsequently, numerous genetic association studies
made the DAOA/G30 gene complex one of the most
intriguing susceptibility loci for the major psychiatric
disorders. The meta-analyses of published association
studies supported weak, but significant genetic effects at
the DAOA/G30 locus to schizophrenia for markers
rs3916964 and rs2391191 or in Asian schizophrenia
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populations for rs947267 and rs778293, and in European
populations for rs1421292 [4-6].
Association between bipolar affective disorder and the
DAOA/G30 locus has first been reported in North
American family-based samples at the intronic marker
rs1935058, with significant association of the entire hap-
lotype set [7]. Further studies missed replication, but
pointed to further associated markers and haplotypes in
case-control samples of US-European ancestry and from
Germany, Poland, Finland and the United Kingdom
[8-13]. The initial meta-analysis found the intronic sin-
gle nucleotide polymorphism (SNP) rs1935062 the most
promising marker (p = 0.0019) [4]. In a more recent
meta-analysis based on four case-control association stu-
dies none of five single markers (used in more than one
study) showed evidence of overall association, but all
SNPs showed significant evidence for heterogeneity
between study designs and study samples [6-9,11].
Regarding genotype-phenotype relations rs3918342
seemed related to psychotic features (persecutory delu-
sions) in bipolar cases, and the ancestral G allele of
rs2391191 (Arg30) to poor visuospatial performance in
bipolars with mania and psychotic symptoms [10,13]. In
a comparison of “core syndromes” of bipolar disorder
and schizophrenia, the DAOA/G30 locus showed overall
association to lifetime episodes of disturbed emotions
more than to psychosis itself [11].
To further elucidate the genetic relevance of DAOA/
G30 for affective disorders, we performed a haplotype
based, case-control association study in a sample of Ger-
man descent in a polydiagnostic approach including the
criteria of ICD-10 and Leonhard’s classification of endo-
genous psychoses. Leonhard’s subphenotypes of bipolar
and monopolar depression represent distinct clinical
and nosological entities avoiding uncertainties by a
switch from unipolar to bipolar depression during
course of disease [14,15].
Methods
Cases were recruited from the Department of Psychiatry,
Psychosomatics and Psychotherapy at of the University of
Würzburg. The sample encompassed 248 cases (154
males, 62%) with affective disorders with a mean age of
48.1 years (+ 15.7 SD) at recruitment. Diagnosis of recur-
rent unipolar depression with “somatic syndrome” (ICD10
F33.11-F33.3), was made in 129 cases and of bipolar affec-
tive disorder in 119 cases [14]. Age at first hospitalization
was 42.7 (+ 16.1 SD) years and 35.9 (+ 12.8 SD) years in
each group, respectively. In addition, cases had to fulfil
diagnostic criteria of monopolar depression (n = 57) and
manic depression (n = 191) according to Leonhard’s
nosology [15]. Diagnosis in differentiated psychopathology
was made by repeated personal examinations of experi-
enced psychiatrists (BJ, GS). The 188 volunteer control
subjects (105 males, 59%) were recruited from the blood
donor centre at the University of Würzburg at a mean age
of 30.2 years (+ 10.7 SD). The preponderance of males in
both samples avoided gender distortion in comparison of
cases and controls. All subjects were unrelated and of
German Caucasian descent. The Ethics Committee of the
University of Würzburg had approved the study, and writ-
ten informed consent was obtained from all subjects.
Genotyping
Matching the DAOA/G30 locus with equally distributed
markers we selected seven SNPs from published studies
or the public databases http://http:www.ncbi.nlm.nih.
gov/; http://genome.ucsc.edu: the intronic SNPs
Figure 1 Gene structure of G72/G30 on chromosome 13q33 and location of genotyped SNPs. The G30 and G72/DAOA locus and
locatiom of the analysed SNPs. G30 exons are marked with yellow, G72 with blue, LD-blocks with orange bars. Arrows indicate orientation on
the chromosomal strand Chromosomal position (nt).
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rs3916966 (M13), rs1935058, rs1935062, rs947267
(M18), the exonic marker rs2391191 (M15; coding for
Arg39Lys), at the 5’-UTR of the DAOA/G30 gene com-
plex rs3918342, and rs9558575 (Figure 1, Table 1)
[3,7,10].
PCR for allelic discrimination was performed in a final
reaction volume of 20 μl containing 20 ng genomic
DNA and 10 μl of 2 × TaqMan®Universal PCR Master
Mix (Applied Biosystems) and 1 μl of 20 × TaqMan™
SNP genotyping assay including fluorescent tags specific
for the wild type allele and the variant allele. Marker
amplification was performed in microtiter plates on Bio-
metra thermocyclers (Whatman). PCR amplification
conditions were according to the manufacturer’s recom-
mendation [10 min at 95°C followed by 15 sec at 92°C
and 60 sec at 60°C for 40 cycles]. Allelic discrimination
with endpoint detection of fluorescence was performed
at 60°C on an ABI prism 7000 sequence detection sys-
tem followed by analysis with an appropriate software
package (Applied Biosystems). All genotype experiments
were made at least in duplicate, with quality control of
automated allele calling by two independent operators
blind to phenotype (0% replicate error rate). Genotyping
was completed for each marker in the total sample (no
missing data). Positive and negative controls are
included routinely in our genotyping experiments.
The exact test proposed by Weir was applied for
Hardy-Weinberg equilibrium. To calculate the pairwise
standardized linkage disequilibrium (LD) coefficient D’
we used the program FAMHAP and the GOLD-software
package [16,17]. Armitage’s trend test was used to com-
pare genotype distributions between cases and controls.
The test hapcc implemented in the program FAMHAP
was used to test all possible SNP combinations (consist-
ing of up to seven SNPS) for their association with the
disease [16,18]. FAMHAP also enables the calculation of
a global/P/-value being corrected for multiple testing.
The statistics on allele and genotype distribution were
uncorrected. Power approximations were calculated with
the program GenOdyPower [19].
Results
Genetic evaluation of the core region of the DAOA/G30
gene complex was based on seven SNPs in a sample of
436 subjects (248 cases; Figure 1). Pairwise linkage dise-
quilibrium (LD)-analysis between the markers confirmed
that a single LD block encompasses all putative exons of
the DAOA/G30 complex, from rs3916966 to the 35 kb
upstream located rs9558575 at nt position 104944661
(Figure 1). SNP-marker rs3918342 is part of a distal LD
block, in low LD with both rs947267 (D’ = 0.28) and
rs9558575 (D’ = 0.33).
No single marker showed evidence of overall associa-
tion with affective disorder (Table 1 and 2). Allele and
genotype frequencies were not significantly different
between cases and controls. The markers were in
Hardy-Weinberg equilibrium (data not shown). We
observed neither gender differences (data not shown)
nor differences in the clinical subgroups according to
ICD10 or Leonhard’s classification (Table 1 and 2).
Regarding unipolar depression or bipolar disorder
according to ICD10, permutation tests for best marker
combinations and best single markers did not reach sta-
tistical significance (Table 3). Gender specific combina-
tions did not appear. Within Leonhard’s classification
manic-depression was significantly associated with a 3-
locus haplotype (rs2391191, rs1935062, and rs3916966;
P = 0.022), whereas monopolar depression was asso-
ciated with a 5-locus combination, containing SNPs of
the DAOA/G30 core region, at P = 0.036 (Table 3).
Discussion
Although positive linkage findings for psychiatric disor-
ders at chromosome 13q and previous genetic associa-
tion studies consider the DAOA/G30 gene complex a
robust candidate for schizophrenia and affective
Table 1 Genotype distribution at the DAOA/G30 locus at chromosome 13q33 according to ICD 10
Controls (n = 188) Bipolar (n = 119) Unipolar (n = 129)
Genotype Genotype Genotype
SNP 11 12 22 MAF HWE 11 12 22 MAF P-value 11 12 22 MAF P-value
rs1935058 (C/T) 32 77 79 0.38 0,09 23 54 42 0.42 0.29 26 56 47 0.42 0.30
rs947267 (C/A) 26 94 68 0.39 0,54 16 56 47 0.37 0.64 20 60 49 0.39 0.99
rs1935062 (A/C) 67 94 27 0.39 0,65 40 65 14 0.39 0.94 50 51 28 0.42 0.60
rs2391191 (A/G) 16 83 89 0.31 0,73 12 52 55 0.32 0.72 20 54 55 0.36 0.13
rs3916966 (A/C) 62 88 38 0.44 0,55 46 55 18 0.38 0.20 48 56 25 0.41 0.54
rs9558575 (G/T) 22 98 68 0.38 0,16 17 51 51 0.36 0.60 18 62 49 0.38 0.95
rs3918342 (C/T) 37 108 43 0.48 0,06 31 65 23 0.47 0.20 30 75 24 0.48 0.29
P-values according to Armitage’s Trend Test
MAF: Minor Allele Frequency
HWE: Hardy-Weinberg Equilibrium
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disorder, there is no consensus about the specific risk
alleles or haplotypes across studies [1,20]. In our case
control study on 436 subjects, individual alleles in the
gene complex were not significantly associated with
affective disorder, neither subdivided according to
ICD10 nor to Leonhard’s classification [14,15]. Our
negative findings on individual markers, thus, corrobo-
rate the data of a recent case-control study in a Scottish
population on narrowly defined bipolar affective disor-
der, a family-based association study of US-European
trios with DSM III-R and DSM IV bipolar I and schi-
zoaffective bipolar type, and of a recent comprehensive
meta-analysis on bipolar samples [6,12,21]. In addition,
multilocus analyses failed to identify associated haplo-
types in unipolar and bipolar depression (Table 3). In
Leonhard’s subtypes of affective psychoses, however,
manic-depression showed a potential association with a
3-locus haplotype spanning ~90 kb, whereas monopolar
depression was associated with a 5-locus haplotype in
the core gene complex.
Our analysis of the LD structure of the DAOA/G30
complex confirms and extends data of earlier studies
that the proximal LD block encompasses all putative
exons of DAOA/G30, reaching from SNP rs3916966 to
the 35 kb upstream located SNP rs9558575, which was
for the first time included in an association analysis
[7,8,22,11,23,24][HapMap project]. No haplotype-tagged
SNP seems to appear. Associated SNPs on the distal
block (i.e. rs3918342 or rs1421292) may, thus, be linked
to regulatory or transcriptional elements of the DAOA/
G30 complex.
To increase the complexity of the G70/G30 locus in
affective disorder, an independent German sample had
reported on a protective two marker haplotype
rs3918342 and rs1421292 for bipolar disorder at the dis-
tal region which is located < 40-50 kb downstream to
the predicted coding region of DAOA/G30 [9]. SNP
rs3918342 was found to be particularly related to psy-
chotic features (persecutory delusions) in this sample
and in a Polish bipolar replication sample [10]. The risk
haplotype rs3918342 and rs142129 appeared also to be
associated with DSM IV recurrent major depression,
whereas more proximal markers showed no association
with disease [23]. Individual case-control and family
based studies on bipolar disorder had reported various
positive single marker and haplotype associations in
European populations, only partially overlapping with
the findings of a recent study on Asian populations
which favoured rs778293 and a two-marker haplotype
rs778294-rs778293 in the distal region for increasing
risk for bipolar disorder [7,9,13,25].
In view of these divergent genetic findings it remains
difficult to conclude whether these differences point to
the genetic autonomy of individual phenotypes,
Table 2 Genotype distribution: Manic and monopolar depression according to Leonhard’s classification
Controls (n = 188) Manic Depression (n = 191) Monopolar Depression (n = 57)
Genotype Genotype Genotype
SNP 11 12 22 MAF HWE 11 12 22 MAF P-value 11 12 22 MAF P-value
rs1935058 (C/T) 32 77 79 0.38 0,09 36 86 69 0.41 0.30 13 24 20 0.44 0.25
rs947267 (C/A) 26 94 68 0.39 0,54 25 89 77 0.36 0.48 11 27 19 0.43 0.42
rs1935062 (A/C) 67 94 27 0.39 0,65 70 93 28 0.39 0.92 20 23 14 0.45 0.31
rs2391191 (A/G) 16 83 89 0.31 0,73 24 78 89 0.33 0.48 8 28 21 0.39 0.10
rs3916966 (A/C) 62 88 38 0.44 0,55 75 85 31 0.38 0.16 19 26 12 0.44 0.96
rs9558575 (G/T) 22 98 68 0.38 0,16 27 82 82 0.36 0.53 8 31 18 0.41 0.48
rs3918342 (C/T) 37 108 43 0.48 0,06 48 109 34 0.46 0.12 13 31 13 0.50 0.75
P-values according to Armitage’s Trend Test
MAF: Minor Allele Frequency
HWE: Hardy-Weinberg Equilibrium
Table 3 Marker combinations at DAOA/G30 locus for association with disease in a polydiagnostic approach
Diagnosis according to ICD 10 best marker combination Global P-value
Unipolar Depression rs1935058, rs947267, rs1935062, rs2391191, rs3916966, rs9558575 0.06
Bipolar Disorder rs1935058, rs1935062, rs2391191, rs3916966, 0.18
Diagnosis according to Leonhard best marker combination
Monopolar Depression rs1935058, rs947267, rs2391191, rs3916966, rs9558575 0.036
Manic Depression rs1935062, rs2391191, rs3916966 0.022
Global P-values according to the analysis with FAMHAP, adjusted for multiple testing.
Best marker combination with the smallest unadjusted P-value.
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represent a common genetic background for affective
disorders. It confirms the importance of rigorous diag-
nostic categorization in affective disorders, the problem
of sample recruitment strategies and the dilemma of
suboptimal power. The strength of our strategy is the
combination of an operational diagnostic approach with
ICD-10 and Leonhard’s categorical diagnostic approach
maximizing homogeneous subgroups, though reducing
power of the sample size. Table 4 exemplifies the differ-
ent groups.
Leonhard’s conception displays some important differ-
ences compared to current conceptions of affective dis-
orders. ICD and DSM have interpreted the diagnostic
criteria of unipolar and bipolar disorders rather broadly.
The concept of “endogenous depression” survived in the
accessory term “somatic syndrome” (ICD10), and diag-
nosis of bipolar disorder is made by the genuine course
knowing that 10-25% of unipolar patients switch to
bipolarity in longitudinal studies [26-28]. Leonhard’s
subphenotypes of monopolar depression are character-
ized by distinct affective syndromes recurring in each
episode with identical symptoms, whereas essential cri-
teria for manic-depression are remitting course and
bipolarity with a melancholic or manic basic syndrome,
presence of mixed states or unipolar partial states with
instability of mood. The melancholic core syndrome is
characterized by depression, psychomotor and thought
inhibition, varying depressive ideas, and somatic symp-
toms and the maniac core syndrome by elevation of
mood, flight of ideas, pressure of speech, elevated self-
consciousness, ideas of grandeur and goal-oriented
activity. Psychotic features like persecutory delusions,
incoherence of speech, mood-incongruent hallucinations
generally do not fit with the diagnosis of manic-depres-
sion in the sense of Leonhard, but are indicative for
cycloid psychoses or unsystematic schizophrenias[15].
Based on these diagnostic criteria, in manic-depression
appears an excessive familial morbidity risk of 35.2%
among first degree relatives compared to population
controls (5.7%) and cycloid psychosis (10.8%) [29].
Our study inherits some limitations as it was directed
at analyzing homogeneous subgroups though reducing
power of the sample size. In comparison with the find-
ings of Schumacher et al. our study has a power (at
alpha = 0.05) of 22.3% for the monopolar depression,
and of 44.4% for the manic depression according to
Leonhard’s classification [9]. According to ICD-10 the
power is 35.2% for the bipolar depression and 36.8% for
the unipolar depression. In addition we cannot exclude
minor impacts by potential flipping of allele calling,
although our LD-data are congruent to previous findings
indicating if any a relative small effect.
Initially, DAOA was thought to be part of the central
dysregulation of the glutamatergic N-methyl-D-aspartate
(NMDA) receptor function, which is thought to be related
to cognitive malfunction in patients with schizophrenia,
depression and other neuropsychiatric disorders by effect-
ing the long-term potentiation (LTP) pathway [3,30,31].
This was questioned by a recent study reporting better
cognitive performance for risk allele carriers [32].
Although existing cDNA libraries proposed expression of
DAOA in the amygdala, caudate nucleus, spinal cord, and
testis, and DAOA and G30 mRNA expression seemed
likely in post-mortem dorsolateral prefrontal cortex of
patients with schizophrenia, no convincing reports regard-
ing expression of native DAOA protein appeared [7,33].
In-vitro immunohistochemical analyses revealed some evi-
dence that DAO and DAOA/G30 are both expressed in
astrocytes of the human cortex, but binding experiments
suggested DAOA more acting as a negative effector of
DAO[34]. The DAOA protein product of 24-kDa was
initially reported to localise at the Golgi apparatus but a
more recent study demonstrated mitochondrial localisa-
tion of overexpressed DAOA [7,35]. Moreover, DAOA
mRNA could not be detected in peripheral tissue samples
and 13 brain regions of the human CNS using reverse
transcriptase (RT)-PCR techniques and northern blotting,
and the protein-protein interaction of DAOA and DAO
failed reproducibility in recombinantly expressed protein
experiments [36,35]. These findings did not support a
putative function of DAOA as general regulator of DAO
in the brain and in glutamatergic signalling either. The
failure to detect expression within various tissues pointed
to an extremely localised or tightly, developmentally regu-
lated expression with a unique spatio-temporal role in
human brain development, independent of an interaction
with DAO [36]. This suggested that if the DAOA protein
exists at all, it is expressed at such low levels that any phy-
siological role is called into question [36]. For the second
gene at the DAOA/G30 gene locus, no protein product
could be verified thus far, suggesting that G30 is a regula-
tor gene of unknown function or just a pseudogene. These
physiological data further challenge a significant role of
the DAOA/G30 gene complex for the aetiology of affective
disorders. In addition to this genome-wide association stu-
dies provided no further evidence for an association of
DAOA with schizophrenia or mood disorders challenging
the previous positive findings [37].
Table 4 Overview of different subgroups according to
Leonhard and ICD 10
ICD 10
bipolar
(n = 119)
ICD 10
unipolar
(n = 129)
Manic Depression according to Leonhard
(n = 191)
119 72
Monopolar Depression according to
Leonhard (n = 57)
0 57
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Conclusion
Despite the uncertainties regarding expression and func-
tion of the DAOA/G30 gene complex, the genetic asso-
ciation of the DAOA/G30 locus to neuropsychiatric
disorders is considered robust, although identification of
true causative variants is still lacking and associated
alleles and haplotypes are not consistent across studies.
Our findings point to partially overlapping risk haplo-
types at the DAOA/G30 locus associated with Leon-
hard’s affective psychoses, but do not support a
common genetic contribution of the DAOA/G30 gene
complex to the pathogenesis of affective disorders.
Author details
1Department of Psychiatry and Psychotherapy, University of Würzburg,
Füchsleinstraße 15, 97080 Würzburg, Germany. 2Institute of Medical
Biometry, Informatics and Epidemiology, University of Bonn, Sigmund-Freud-
Str. 25, 53105 Bonn, Germany. 3Department of Forensic Medicine, University
of Würzburg, Lindleinstraße 15, 97080 Würzburg, Germany. 4Coordination
Centre for Clinical Trials, University of Leipzig, Härtelstraße 16-18, 04107
Leipzig, Germany.
Authors’ contributions
MG carried out the molecular genetic studies and drafting of the
manuscript, IW performed laboratory assays, SJ participated in the
coordination of the study. BP and BJ participated in the diagnostic
evaluation of the patients, MM and MK contributed the data-analysis,
interpretation of the data and drafting of the manuscript, GS initiated and
coordinated the study. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 15 October 2009 Accepted: 29 July 2010
Published: 29 July 2010
References
1. Badner JA, Gershon ES: Meta-analysis of whole-genome linkage scans of
bipolar disorder and schizophrenia. Molecular Psychiatry 2002, 7:405-411.
2. Jamra RA, Schmael C, Cichon S, Rietschel M, Schumacher J, Nöthen MM:
The G72/G30 gene locus in psychiatric disorders: a challenge to
diagnostic boundaries? Schizophr Bull 2006, 32:599-608.
3. Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M,
Abderrahim H, Bougueleret L, Barry C, Tanaka H, La Rosa P, Puech A,
Tahri N, Cohen-Akenine A, Delabrosse S, Lissarrague S, Picard FP, Maurice K,
Essioux L, Millasseau P, Grel P, Debailleul V, Simon AM, Caterina D,
Dufaure I, Malekzadeh K, Belova M, Luan J, Bouillot M, Sambucy JL,
Primas G, Saumier M, Boubkiri N, Martin-Saumier S, Nasroune M, Peixoto H,
Delaye A, Pinchot V, Bastucci M, Guillou S, Chevillon M, Sainz-Fuertes R,
Meguenni S, Aurich-Costa J, Cherif D, Gimalac A, Van Duijn C, Gauvreau D,
Ouellett G, Fortier I, Raelson J, Sherbatich T, Riazanskaia N, Rogaevm E,
Raeymaekers P, Aerssens J, Konings F, Luyten W, Macciardi F, Sham PC,
Straub RE, Weinberger DR, Cohen N, Cohen D: Genetic and physiological
data implicating the new human gene G72 and the gene for D-amino
acid oxidase in schizophrenia. Proceedings of the National Academy of
Sciences 2002, 99:13675-13680.
4. Detera-Wadleigh SD, McMahon FJ: G72/G30 in Schizophrenia and Bipolar
Disorder: Review and Meta-analysis. Biological Psychiatry 2006, 60:106-14.
5. Li D, He L: G72/G30 genes and schizophrenia: a systematic meta-analysis
of association studies. Genetics 2007, 175:917-22.
6. Shi J, Badner JA, Gershon ES, Chunyu L, Willour VL, Potash JB: Further
evidence for an association of G72/G30 with schizophrenia in Chinese.
Schizophr Res 2009, 107:324-6.
7. Hattori E, Liu C, Badner JA, Bonner TI, Christian SL, Maheshwari M, Detera-
Wadleigh SD, Gibbs RA, Gershon ES: Polymorphisms at the G72/G30 gene
locus, on 13q33, are associated with bipolar disorder in two
independent pedigree series. American journal of human genetics 2003,
72:1131-40.
8. Chen YS, Akula N, Detera-Wadleigh SD, Schulze TG, Thomas J, Potash JB,
DePaulo JR, McInnis MG, Cox NJ, McMahon FJ: Findings in an
independent sample support an association between bipolar affective
disorder and the G72/G30 locus on chromosome 13q33. Molecular
Psychiatry 2004, 9:87-92.
9. Schumacher J, Jamra RA, Freudenberg J, Becker T, Ohlraun S, Otte ACJ,
Tullius M, Kovalenko S, Van Den Bogaert A, Maier W, Rietschel M,
Propping P, Nothen MM, Cichon S: Examination of G72 and D-amino-acid
oxidase as genetic risk factors for schizophrenia and bipolar affective
disorder. Molecular Psychiatry 2004, 9:203-207.
10. Schulze TG, Ohlraun S, Czerski PM, Schumacher J, Kassem L, Deschner M,
Gross M, Tullius M, Heidmann V, Kovalenko S, Jamra RA, Becker T,
Leszczynska-Rodziewicz A, Hauser J, Illig T, Klopp N, Wellek S, Cichon S,
Henn FA, McMahon FJ, Maier W, Propping P, Nöthen MM, Rietschel M:
Genotype-Phenotype Studies in Bipolar Disorder Showing Association
Between the DAOA/G30 Locus and Persecutory Delusions: A First Step
Toward a Molecular Genetic Classification of Psychiatric Phenotypes. The
American Journal of Psychiatry 2005, 162:2101-2108.
11. Williams NM, Green EK, Macgregor S, Dwyer S, Norton N, Williams H,
Raybould R, Grozeva D, Hamshere M, Zammit S, Jones L, Cardno A, Kirov G,
Jones I, O’Donovan MC, Owen MJ, Craddock N: Variation at the DAOA/
G30 Locus Influences Susceptibility to Major Mood Episodes but Not
Psychosis in Schizophrenia and Bipolar Disorder. Archives of general
psychiatry 2006, 63:366-73.
12. Prata D, Breen G, Osborne S, Munro J, St Clair D, Collier D: Association of
DAO and G72(DAOA)/G30 genes with bipolar affective disorder. Am J
Med Genet B Neuropsychiatr Genet 2008, 147B:14-7.
13. Soronen P, Silander K, Antila M, Palo OM, Tuulio-Henriksson A, Kieseppä T,
Ellonen P, Wedenoja J, Turunen JA, Pietiläinen OP, Hennah W, Lönnqvist J,
Peltonen L, Partonen T, Paunio T: Association of a nonsynonymous
variant of DAOA with visuospatial ability in a bipolar family sample. Biol
Psychiatry 2008, 64:438-442.
14. World Health Organization (WHO): The ICD-10 Classification of Mental and
Behavioural Disorders. WHO, Geneva 1993.
15. Leonhard K: Classification of endogenous psychoses and their
differentiated etiology. Wien, New York: Springer 1999, 2nd rev. and
enlarged.
16. Becker T, Knapp M: Maximum likelihood estimation of haplotype
frequencies in nuclear families. Genetic epidemiology 2004, 27:21-32.
17. Abecasis GR, Cookson WO: GOLD - graphical overview of linkage
disequilibrium. Bioinformatics 2000, 16:182-3.
18. Becker T, Knapp M: A powerful strategy to account for multiple testing in
the contextof haplotype analysis. Am J Hum Genet 2004, 75:561-570.
19. Jackson MR, Genin E, Knapp M, Escary JL: Accurate power approximations
for 2 tests in case-control association studies of complex disease genes.
Ann Hum Genet 2002, 66:307-321.
20. Sklar P: Linkage analysis in psychiatric disorders: the emerging picture.
Annu Rev Genomics Hum Genet 2002, 3:371-413.
21. Maheshwari M, Shi J, Badner JA, Skol A, Willour VL, Muzny DM, Wheeler DA,
Gerald FR, Detera-Wadleigh S, McMahon FJ, Potash JB, Gershon ES, Liu C,
Gibbs RA: Common and rare variants of DAOA in bipolar disorder. Am J
Med Genet B Neuropsychiatr Genet 2009.
22. Abou Jamra R, Schmael C, Cichon S, Rietschel M, Schumacher J,
Nöthen MM: The G72/G30 gene locus in psychiatric disorders: a
challenge to diagnostic boundaries? Schizophr Bull 2006, 32:599-608.
23. Rietschel M, Beckmann L, Strohmaier J, Georgi A, Karpushova A,
Schirmbeck F, Boesshenz KV, Schmäl C, Bürger C, Jamra RA, Schumacher J,
Höfels S, Kumsta R, Entringer S, Krug A, Markov V, Maier W, Propping P,
Wüst S, Kircher T, Nöthen MM, Cichon S, Schulze TG: G72 and its
association with major depression and neuroticism in large population-
based groups from Germany. Am J Psychiatry 2008, 165:753-62.
24. Opgen-Rhein C, Lencz T, Burdick KE, Neuhaus AH, DeRosse P, Goldberg TE,
Malhotra AK: Genetic variation in the DAOA gene complex: impact on
susceptibility for schizophrenia and on cognitive performance. Schizophr
Res 2008, 103:169-177.
25. Zhang Z, Li Y, Zhao Q, Huang K, Wang P, Yang P, Li S, Feng G,
Lindpaintner K, He L, Shi Y: First evidence of association between G72
and bipolar disorder in the Chinese Han population. Psychiatr Genet 2009,
19:151-3.
Gawlik et al. BMC Psychiatry 2010, 10:59
http://www.biomedcentral.com/1471-244X/10/59
Page 6 of 7
26. Tsuang MT, Woolson RF, Winokur G, Crowe RR: Stability of psychiatric
diagnosis. Schizophrenia and affective disorders followed up over a 30-
to 40-year period. Arch Gen Psychiatry 1981, 38:535-539.
27. Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Keller M, Warshaw M,
Clayton P, Goodwin F: Switching from unipolar’ to bipolar II. An 11-year
prospective study of clinical and temperamental predictors in 559
patients. Arch Gen Psychiatry 1995, 52:114-123.
28. Schwartz JE, Fennig S, Tanenberg-Karant M, Carlson G, Craig T, Galambos N,
Lavelle Bromet EJ: Congruence of diagnoses 2 years after a first-
admission diagnosis of psychosis. Arch Gen Psychiatry 2000, 57:593-596.
29. Pfuhlmann B, Jabs B, Althaus G, Schmidtke A, Bartsch A, Stoeber G,
Beckmann H, Franzek E: Cycloid psychoses are not part of a bipolar
affective spectrum. Results of a controlled family study. Journal of
Affective Disorders 2004, 83:11-19.
30. Robbins TW, Murphy ER: Behavioural pharmacology: 40+ years of
progress, with a focus on glutamate receptors and cognition. Trends
Pharmacol Sci 2006, 27:141-148.
31. Yashiro K, Philpot BD: Regulation of NMDA receptor subunit expression
and its implications for LTD, LTP, and metaplasticity. Neuropharmacology
2008, 55:1081-1094.
32. Jansen A, Krach S, Krug A, Markov V, Eggermann T, Zerres K, Thimm M,
Nothen MM, Treutlein J, Rietschel M, Kircher T: Effect of the G72 (DAOA)
putative risk haplotype on cognitive functions in healthy subjects. BMC
Psychiatry 2009, 9:60.
33. Korostishevsky M, Kaganovich M, Cholostoy A, Ashkenazi M, Ratner Y,
Dahary D, Bernstein J, Bening-Abu-Shach U, Ben Asher E, Lancet D,
Ritsner M, Navon R: Is the G72/G30 locus associated with schizophrenia?
Single nucleotide polymorphisms, haplotypes, and gene expression
analysis. Biol Psychiatry 2004, 56:169-176.
34. Sacchi S, Bernasconi M, Martineau M, Mothet JP, Ruzzene M, Pilone MS,
Pollegioni L, Molla G: pLG72 modulates intracellular D-serine levels
through its interaction with D-amino acid oxidase: effect on
schizophrenia susceptibility. J Biol Chem 2008, 283:22244-22256.
35. Kvajo M, Dhilla A, Swor DE, Karayiorgou M, Gogos JA: Evidence implicating
the candidate schizophrenia/bipolar disorder susceptibility gene G72 in
mitochondrial function. Mol Psychiatry 2008, 13:685-696.
36. Benzel I, Kew JN, Viknaraja R, Kelly F, de Belleroche J, Hirsch S,
Sanderson TH, Maycox PR: Investigation of G72 (DAOA) expression in the
human brain. BMC Psychiatry 2008, 8:94.
37. McMahon FJ, Akula N, Schulze TG, Muglia P, Tozzi F, Detera-Wadleigh SD,
Steele CJ, Breuer R, Strohmaier J, Wendland JR, Mattheisen M,
Mühleisen TW, Maier W, Nöthen MM, Cichon S, Farmer A, Vincent JB,
Holsboer F, Preisig M, Rietschel M: Meta-analysis of genome-wide
association data identifies a risk locus for major mood disorders on
3p21.1. Nat Genet 2010, 42:128-31.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-244X/10/59/prepub
doi:10.1186/1471-244X-10-59
Cite this article as: Gawlik et al.: The DAOA/G30 locus and affective
disorders: haplotype based association study in a polydiagnostic
approach. BMC Psychiatry 2010 10:59.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Gawlik et al. BMC Psychiatry 2010, 10:59
http://www.biomedcentral.com/1471-244X/10/59
Page 7 of 7
